DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
VEEV logo

Veeva Systems Inc. Stock Price

NYSE:VEEV Community·US$42.2b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 290 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

VEEV Share Price Performance

US$260.98
-18.49 (-6.62%)
​
US$251.43
Fair Value
US$260.98
-18.49 (-6.62%)
3.8% overvalued intrinsic discount
US$251.43
Fair Value
Price US$260.98
AnalystConsensusTarget US$251.43
John_Eric US$383.14
AnalystHighTarget US$338.31
Thu, 20 Aug 26
Fair ValueUS$251.43
Share Pricen/a

VEEV Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$251.43 3.8% overvalued intrinsic discount

Pharma Wins And New Partnerships Will Drive Cloud Momentum In Coming Quarters

3users have liked this narrative
0users have commented on this narrative
120users have followed this narrative
JO
John_Eric
John_Eric's
Fair Value
·
Fair Value US$383.14 31.9% undervalued intrinsic discount

AI-Powered Veeva Systems Poised for Solid Growth Amid Regulatory Stability

6users have liked this narrative
0users have commented on this narrative
46users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$338.31 22.9% undervalued intrinsic discount

Rising Life Sciences Cloud Standardization And AI Adoption Will Support Strong Long Term Upside

1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
VEEV logo
Veeva Systems
31.9% undervalued intrinsic discount

AI-Powered Veeva Systems Poised for Solid Growth Amid Regulatory Stability

View narrative
JO
John_Eric
Emerging Author
John_Eric
Updated 27 Aug
Read Narrative
VEEV logo
Veeva Systems
3.8% overvalued intrinsic discount

Pharma Wins And New Partnerships Will Drive Cloud Momentum In Coming Quarters

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 20 Aug
Read Narrative
VEEV logo
Veeva Systems
14.6% overvalued intrinsic discount

AI And Data Expansion Will Define Future Potential While Current Risks Keep Expectations Tame

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
VEEV logo
Veeva Systems
22.9% undervalued intrinsic discount

Rising Life Sciences Cloud Standardization And AI Adoption Will Support Strong Long Term Upside

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 29 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

JO
John_Eric
VEEV logo

Veeva Just Had a Great Quarter. That's Exactly Why I'm Not Buying More.

Fair Value: US$383.14 31.9% undervalued intrinsic discount
46 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
1 likeusers have liked this narrative
AN
AnalystLowTarget
VEEV logo

VEEV: Elevated AI Optimism Will Pressure CRM Expectations Going Forward

Fair Value: US$227.65 14.6% overvalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
VEEV logo

VEEV: AI Demand And CRM Wins Will Support Balanced Future Returns

Fair Value: US$251.43 3.8% overvalued intrinsic discount
120 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
3 Rewards
View Full Analysis

Veeva Systems Inc. Key Details

US$3.5b

Revenue

US$865.9m

Cost of Revenue

US$2.6b

Gross Profit

US$1.6b

Other Expenses

US$1.0b

Earnings

Last Reported Earnings
Jul 31, 2026
Next Reporting Earnings
n/a
6.27
74.96%
29.34%
0%
View Full Analysis

About VEEV

Founded
2007
Employees
7928
CEO
Peter Gassner
WebsiteView website
www.veeva.com

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Recent VEEV News & Updates

User avatar
Narrative Update • Sep 03

VEEV: Elevated AI Optimism Will Pressure CRM Expectations Going Forward

Analysts have lifted their fair value estimate for Veeva Systems from $165.00 to about $227.65, reflecting higher assumed revenue growth and a richer future P/E multiple, partly supported by recent price target increases tied to expected billings strength, CRM wins, and perceived insulation from AI disruption. Analyst Commentary Recent Street research on Veeva Systems highlights a generally constructive view, with several firms lifting price targets and pointing to strengths in CRM, subscription growth and the company’s positioning around AI.

Recent updates

No updates

Veeva Systems Inc. Competitors

ABT logo

Abbott Laboratories

Symbol: NYSE:ABT
Market cap: US$182.1b
ISRG logo

Intuitive Surgical

Symbol: NasdaqGS:ISRG
Market cap: US$124.8b
CVS logo

CVS Health

Symbol: NYSE:CVS
Market cap: US$122.0b
MDT logo

Medtronic

Symbol: NYSE:MDT
Market cap: US$117.5b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide